TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Multinational Trial of the Efficacy of Albendazole Against Soil-transmitted Nematode Infections in Children
Brief Summary: The three major Soil-Transmitted Helminths (STH), Ascaris lumbricoides, Necator americanus/Ancylostoma duodenal and Trichuris trichiura are among the most prevalent parasites worldwide. The objective of this multicentre international study is to define the efficacy of a single 400 milligram dose of albendazole (ALB) against these three STHs using a standardised protocol. The trial will be undertaken among school age children in seven countries - Brazil, Cameroon, Cambodia, Ethiopia, India, Tanzania (Zanzibar) and Vietnam - each with a different epidemiologic pattern of infection. A trial of this nature is urgently required because in spite of the wide usage of albendazole over the last 3 decades, there is still no key publication reporting the efficacy of the anthelmintic accurately, and to modern conventional standards, that can act as a central reference for the baseline efficacy. The latter is critically important because albendazole is now being used even more widely, as large scale mass treatment campaigns are being implemented in Africa and elsewhere, with the intention of reducing morbidity in children. Such large scale usage of a drug risks resistance developing, but resistance cannot be detected unless benchmark values for baseline efficacy are widely known.


Options:
A: Arm Label: Albendazole; Type: EXPERIMENTAL; Interventions: Drug: Albendazole | Intervention Type: DRUG; Name: Albendazole; Assigned to Arm(s): Albendazole
B: Arm Label: Papaya seed porridge; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Ujiplus | Arm Label: Albendazole and Plain porridge; Type: ACTIVE_COMPARATOR; Interventions: Drug: Albendazole | Arm Label: Plain porridge; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: uji | Intervention Type: DIETARY_SUPPLEMENT; Name: Ujiplus; Assigned to Arm(s): Papaya seed porridge | Intervention Type: DRUG; Name: Albendazole; Assigned to Arm(s): Albendazole and Plain porridge | Intervention Type: DIETARY_SUPPLEMENT; Name: uji; Assigned to Arm(s): Plain porridge
C: Arm Label: Single dose of mebendazole; Type: ACTIVE_COMPARATOR; Interventions: Drug: Treatment with one of the two regimens of mebendazole | Arm Label: Multiple dose of mebendazole; Type: ACTIVE_COMPARATOR; Interventions: Drug: Treatment with one of the two regimens of mebendazole | Intervention Type: DRUG; Name: Treatment with one of the two regimens of mebendazole; Assigned to Arm(s): Multiple dose of mebendazole, Single dose of mebendazole
D: Arm Label: Mebendazole; Type: EXPERIMENTAL; Interventions: Drug: Mebendazole | Intervention Type: DRUG; Name: Mebendazole; Assigned to Arm(s): Mebendazole

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Hormonal Replacement Therapy Does Not Affect Self-estimated Pain or Experimental Pain Responses in Postmenopausal Women Suffering From Fibromyalgia: A Double-blind, Randomized, Placebo-controlled Trial
Brief Summary: In order to evaluate the potential effects of estrogen treatment in postmenopausal women with fibromyalgia, the investigators used quantitative sensory tests before and after eight weeks of estrogen treatment as compared with placebo treatment.


Options:
A: Intervention Type: DRUG; Name: estradiol gel; Assigned to Arm(s): N/A
B: Arm Label: Tibolone; Type: ACTIVE_COMPARATOR; Interventions: Drug: tibolone | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Intervention Type: DRUG; Name: tibolone; Assigned to Arm(s): Tibolone | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): Placebo
C: Arm Label: faslodex+placebo; Type: EXPERIMENTAL; Interventions: Drug: faslodex 500mg, Drug: arimidex dummy | Arm Label: arimidex +placebo; Type: ACTIVE_COMPARATOR; Interventions: Drug: arimidex 1mg, Drug: faslodex dummy | Intervention Type: DRUG; Name: faslodex 500mg; Assigned to Arm(s): faslodex+placebo | Intervention Type: DRUG; Name: arimidex 1mg; Assigned to Arm(s): arimidex +placebo | Intervention Type: DRUG; Name: faslodex dummy; Assigned to Arm(s): arimidex +placebo | Intervention Type: DRUG; Name: arimidex dummy; Assigned to Arm(s): faslodex+placebo
D: Arm Label: Treatment with transdermal 17β-estradiol; Type: EXPERIMENTAL; Interventions: Drug: 17β-estradiol | Arm Label: Control; Type: PLACEBO_COMPARATOR; Interventions: Drug: 17β-estradiol | Intervention Type: DRUG; Name: 17β-estradiol; Assigned to Arm(s): Control, Treatment with transdermal 17β-estradiol

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effect of Novel Medical Food on Reducing the Frequency and Severity of Asthma Symptoms and Airway Hyper-responsiveness in Children With Mild to Moderate Persistent Asthma
Brief Summary: To determine the effect of medical food on reducing asthma symptoms in asthmatic children.


Options:
A: Arm Label: Integrative Medicine; Type: EXPERIMENTAL; Interventions: Behavioral: Integrative Medicine | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Integrative Medicine; Assigned to Arm(s): Integrative Medicine
B: Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: DASH Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Dietary Approaches to Stop Hypertension dietary pattern | Intervention Type: BEHAVIORAL; Name: Dietary Approaches to Stop Hypertension dietary pattern; Assigned to Arm(s): DASH Intervention
C: Arm Label: novel nutritional formula; Type: EXPERIMENTAL; Interventions: Other: medical food with EPA and GLA, vitamins and minerals | Arm Label: Control nutritional product; Type: ACTIVE_COMPARATOR; Interventions: Other: medical food minus EPA and GLA, antioxidant vitamins/minerals | Intervention Type: OTHER; Name: medical food with EPA and GLA, vitamins and minerals; Assigned to Arm(s): novel nutritional formula | Intervention Type: OTHER; Name: medical food minus EPA and GLA, antioxidant vitamins/minerals; Assigned to Arm(s): Control nutritional product
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Aspirin, Drug: Vitamin E | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Drug: Vitamin E, Behavioral: Placebo | Arm Label: 3; Type: EXPERIMENTAL; Interventions: Drug: Aspirin, Behavioral: Placebo | Arm Label: 4; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Placebo | Intervention Type: DRUG; Name: Aspirin; Assigned to Arm(s): 1, 3 | Intervention Type: DRUG; Name: Vitamin E; Assigned to Arm(s): 1, 2 | Intervention Type: BEHAVIORAL; Name: Placebo; Assigned to Arm(s): 2, 3, 4

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effect of Novel Medical Food on Reducing the Frequency and Severity of Asthma Symptoms and Airway Hyper-responsiveness in Children With Mild to Moderate Persistent Asthma
Brief Summary: To determine the effect of medical food on reducing asthma symptoms in asthmatic children.


Options:
A: Arm Label: novel nutritional formula; Type: EXPERIMENTAL; Interventions: Other: medical food with EPA and GLA, vitamins and minerals | Arm Label: Control nutritional product; Type: ACTIVE_COMPARATOR; Interventions: Other: medical food minus EPA and GLA, antioxidant vitamins/minerals | Intervention Type: OTHER; Name: medical food with EPA and GLA, vitamins and minerals; Assigned to Arm(s): novel nutritional formula | Intervention Type: OTHER; Name: medical food minus EPA and GLA, antioxidant vitamins/minerals; Assigned to Arm(s): Control nutritional product
B: Intervention Type: DRUG; Name: Budesonide/formoterol Turbuhaler; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Salmeterol/fluticasone Diskus; Assigned to Arm(s): N/A
C: Intervention Type: DRUG; Name: Budesonide/formoterol; Assigned to Arm(s): N/A
D: Intervention Type: DRUG; Name: budesonide/formoterol Turbuhaler; Assigned to Arm(s): N/A

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effect of Novel Medical Food on Reducing the Frequency and Severity of Asthma Symptoms and Airway Hyper-responsiveness in Children With Mild to Moderate Persistent Asthma
Brief Summary: To determine the effect of medical food on reducing asthma symptoms in asthmatic children.


Options:
A: Arm Label: Esomeprazole; Type: EXPERIMENTAL; Interventions: Drug: Esomeprazole | Arm Label: Placebo for esomeprazoe; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo proton pump inhibitor | Intervention Type: DRUG; Name: Esomeprazole; Assigned to Arm(s): Esomeprazole | Intervention Type: DRUG; Name: Placebo proton pump inhibitor; Assigned to Arm(s): Placebo for esomeprazoe
B: Arm Label: novel nutritional formula; Type: EXPERIMENTAL; Interventions: Other: medical food with EPA and GLA, vitamins and minerals | Arm Label: Control nutritional product; Type: ACTIVE_COMPARATOR; Interventions: Other: medical food minus EPA and GLA, antioxidant vitamins/minerals | Intervention Type: OTHER; Name: medical food with EPA and GLA, vitamins and minerals; Assigned to Arm(s): novel nutritional formula | Intervention Type: OTHER; Name: medical food minus EPA and GLA, antioxidant vitamins/minerals; Assigned to Arm(s): Control nutritional product
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Aspirin, Drug: Vitamin E | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Drug: Vitamin E, Behavioral: Placebo | Arm Label: 3; Type: EXPERIMENTAL; Interventions: Drug: Aspirin, Behavioral: Placebo | Arm Label: 4; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Placebo | Intervention Type: DRUG; Name: Aspirin; Assigned to Arm(s): 1, 3 | Intervention Type: DRUG; Name: Vitamin E; Assigned to Arm(s): 1, 2 | Intervention Type: BEHAVIORAL; Name: Placebo; Assigned to Arm(s): 2, 3, 4
D: Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: DASH Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Dietary Approaches to Stop Hypertension dietary pattern | Intervention Type: BEHAVIORAL; Name: Dietary Approaches to Stop Hypertension dietary pattern; Assigned to Arm(s): DASH Intervention

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Metformin Versus Insulin in the Treatment of Gestational Diabetes Mellitus: a Randomized Controlled Study
Brief Summary: The purpose of this study is to determine if metformin therapy prevents fetal macrosomy in gestational diabetes mellitus to the same extent as insulin therapy.


Options:
A: Arm Label: Glyburide (Glyburide vs Insulin); Type: N/A; Interventions: Drug: Glyburide vs Insulin trials | Arm Label: Insulin (Glyburide vs Insulin); Type: N/A; Interventions: Drug: Glyburide vs Insulin trials | Arm Label: Metformin (Metformin vs Insulin); Type: N/A; Interventions: Drug: Metformin vs Insulin trials | Arm Label: Insulin (Metformin vs Insulin); Type: N/A; Interventions: Drug: Metformin vs Insulin trials | Arm Label: Metformin (Metformin vs Glyburide); Type: N/A; Interventions: Drug: Metformin vs Glyburide trials | Arm Label: Glyburide (Metformin vs Glyburide); Type: N/A; Interventions: Drug: Metformin vs Glyburide trials | Intervention Type: DRUG; Name: Glyburide vs Insulin trials; Assigned to Arm(s): Glyburide (Glyburide vs Insulin), Insulin (Glyburide vs Insulin) | Intervention Type: DRUG; Name: Metformin vs Insulin trials; Assigned to Arm(s): Insulin (Metformin vs Insulin), Metformin (Metformin vs Insulin) | Intervention Type: DRUG; Name: Metformin vs Glyburide trials; Assigned to Arm(s): Glyburide (Metformin vs Glyburide), Metformin (Metformin vs Glyburide)
B: Arm Label: Metformin; Type: EXPERIMENTAL; Interventions: Drug: Metformin | Arm Label: Insulin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Insulin | Intervention Type: DRUG; Name: Metformin; Assigned to Arm(s): Metformin | Intervention Type: DRUG; Name: Insulin; Assigned to Arm(s): Insulin
C: Arm Label: Metformin; Type: EXPERIMENTAL; Interventions: Drug: Metformin | Arm Label: Insulin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Insulin | Intervention Type: DRUG; Name: Metformin; Assigned to Arm(s): Metformin | Intervention Type: DRUG; Name: Insulin; Assigned to Arm(s): Insulin
D: Arm Label: metformin; Type: EXPERIMENTAL; Interventions: Drug: Metformin | Arm Label: insulin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Insulin | Intervention Type: DRUG; Name: Metformin; Assigned to Arm(s): metformin | Intervention Type: DRUG; Name: Insulin; Assigned to Arm(s): insulin

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomized Trial of the Innovative Neurotronics WalkAide Compared to Conventional Ankle-Foot Orthosis (AFO) in Stroke Patients (INSTRIDE)
Brief Summary: To establish equivalence or incremental benefit to standard of care Ankle-Foot Orthosis (AFO) for patients with foot drop due to stroke, and to assess the functional improvement of ambulation and improved activities of daily living.


Options:
A: Arm Label: IpsiHand; Type: EXPERIMENTAL; Interventions: Device: IpsiHand Device | Intervention Type: DEVICE; Name: IpsiHand Device; Assigned to Arm(s): IpsiHand
B: Arm Label: Ankle-Foot Orthosis (AFO); Type: ACTIVE_COMPARATOR; Interventions: Other: Ankle-Foot Orthosis (AFO) | Arm Label: WalkAide; Type: ACTIVE_COMPARATOR; Interventions: Device: WalkAide | Intervention Type: DEVICE; Name: WalkAide; Assigned to Arm(s): WalkAide | Intervention Type: OTHER; Name: Ankle-Foot Orthosis (AFO); Assigned to Arm(s): Ankle-Foot Orthosis (AFO)
C: Arm Label: Ankle-foot orthosis (AFO) Control Group; Type: ACTIVE_COMPARATOR; Interventions: Device: Ankle-foot orthosis | Arm Label: Ness L300 Treatment Group; Type: EXPERIMENTAL; Interventions: Device: Ness L300 | Intervention Type: DEVICE; Name: Ness L300; Assigned to Arm(s): Ness L300 Treatment Group | Intervention Type: DEVICE; Name: Ankle-foot orthosis; Assigned to Arm(s): Ankle-foot orthosis (AFO) Control Group
D: Arm Label: ODFS; Type: EXPERIMENTAL; Interventions: Device: Odstock Dropped-Foot Stimulator (ODFS), Procedure: Traditional Physical Therapy Treatment | Arm Label: Standard of Care (inc. AFO); Type: ACTIVE_COMPARATOR; Interventions: Other: Conventional Standard of Care, Procedure: Traditional Physical Therapy Treatment | Intervention Type: DEVICE; Name: Odstock Dropped-Foot Stimulator (ODFS); Assigned to Arm(s): ODFS | Intervention Type: OTHER; Name: Conventional Standard of Care; Assigned to Arm(s): Standard of Care (inc. AFO) | Intervention Type: PROCEDURE; Name: Traditional Physical Therapy Treatment; Assigned to Arm(s): ODFS, Standard of Care (inc. AFO)

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Levonorgestrel-Intrauterine System (LNG-IUS) Insertion in the Postpartum Period: A Prospective, Randomized Pilot Study of Three Time Intervals
Brief Summary: The investigators study is a prospective randomized trial of women undergoing the levonorgestrel intrauterine system (LNG-IUS: Mirena©, Bayer) at three separate time periods: immediate post placental (IPP) defined as insertion within 10 min delivery of placenta, early post partum (EP) defined as insertion after 10 min but within 72hrs postpartum, or interval (INT) insertion defined as insertion after 6wks postpartum. This is a pilot study in preparation for a multicenter, prospective randomized study of long-acting reversible contraception in the postpartum period.


Options:
A: Arm Label: Interval IUD Placement; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Immediate Postplacental IUD placement; Type: EXPERIMENTAL; Interventions: Device: Immediate Postplacental Placement of an IUD during cesarean delivery | Intervention Type: DEVICE; Name: Immediate Postplacental Placement of an IUD during cesarean delivery; Assigned to Arm(s): Immediate Postplacental IUD placement
B: Arm Label: Immediate Postplacental; Type: EXPERIMENTAL; Interventions: Device: Levonorgestrel Intrauterine System (LNG-IUS: Mirena, Bayer) | Arm Label: Early Postpartum; Type: EXPERIMENTAL; Interventions: Device: Levonorgestrel Intrauterine System (LNG-IUS: Mirena, Bayer) | Arm Label: Interval; Type: EXPERIMENTAL; Interventions: Device: Levonorgestrel Intrauterine System (LNG-IUS: Mirena, Bayer) | Intervention Type: DEVICE; Name: Levonorgestrel Intrauterine System (LNG-IUS: Mirena, Bayer); Assigned to Arm(s): Early Postpartum, Immediate Postplacental, Interval
C: Arm Label: postplacental insertion after cesarean; Type: EXPERIMENTAL; Interventions: Device: Levonorgestrel-releasing intrauterine system (LNG-IUS) | Arm Label: delayed insertion group; Type: ACTIVE_COMPARATOR; Interventions: Device: Levonorgestrel-releasing intrauterine system (LNG-IUS) | Intervention Type: DEVICE; Name: Levonorgestrel-releasing intrauterine system (LNG-IUS); Assigned to Arm(s): postplacental insertion after cesarean | Intervention Type: DEVICE; Name: Levonorgestrel-releasing intrauterine system (LNG-IUS); Assigned to Arm(s): delayed insertion group
D: Arm Label: Levonorgestrel (LNG) implants immediately postpartum; Type: ACTIVE_COMPARATOR; Interventions: Device: Jadelle | Arm Label: Levonorgestrel (LNG) implants 6 weeks postpartum; Type: ACTIVE_COMPARATOR; Interventions: Device: Jadelle | Intervention Type: DEVICE; Name: Jadelle; Assigned to Arm(s): Levonorgestrel (LNG) implants immediately postpartum | Intervention Type: DEVICE; Name: Jadelle; Assigned to Arm(s): Levonorgestrel (LNG) implants 6 weeks postpartum

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Levonorgestrel-Intrauterine System (LNG-IUS) Insertion in the Postpartum Period: A Prospective, Randomized Pilot Study of Three Time Intervals
Brief Summary: The investigators study is a prospective randomized trial of women undergoing the levonorgestrel intrauterine system (LNG-IUS: Mirena©, Bayer) at three separate time periods: immediate post placental (IPP) defined as insertion within 10 min delivery of placenta, early post partum (EP) defined as insertion after 10 min but within 72hrs postpartum, or interval (INT) insertion defined as insertion after 6wks postpartum. This is a pilot study in preparation for a multicenter, prospective randomized study of long-acting reversible contraception in the postpartum period.


Options:
A: Arm Label: Postplacental IUD insertion; Type: EXPERIMENTAL; Interventions: Device: Levonorgestrel-releasing IUD (Mirena) | Arm Label: Delayed IUD insertion; Type: ACTIVE_COMPARATOR; Interventions: Device: Levonorgestrel-releasing IUD (Mirena) | Intervention Type: DEVICE; Name: Levonorgestrel-releasing IUD (Mirena); Assigned to Arm(s): Delayed IUD insertion, Postplacental IUD insertion
B: Arm Label: Immediate postpartum IUD insertion; Type: EXPERIMENTAL; Interventions: Device: Copper T380A Intrauterine Device | Arm Label: 6 week postpartum IUD insertion; Type: EXPERIMENTAL; Interventions: Device: Copper T380A Intrauterine Device | Intervention Type: DEVICE; Name: Copper T380A Intrauterine Device; Assigned to Arm(s): 6 week postpartum IUD insertion, Immediate postpartum IUD insertion
C: Arm Label: 6 weeks interval insertion; Type: OTHER; Interventions: Other: 6 weeks interval insertion | Arm Label: Immediate insertion; Type: EXPERIMENTAL; Interventions: Other: Immediate insertion | Intervention Type: OTHER; Name: Immediate insertion; Assigned to Arm(s): Immediate insertion | Intervention Type: OTHER; Name: 6 weeks interval insertion; Assigned to Arm(s): 6 weeks interval insertion
D: Arm Label: Immediate Postplacental; Type: EXPERIMENTAL; Interventions: Device: Levonorgestrel Intrauterine System (LNG-IUS: Mirena, Bayer) | Arm Label: Early Postpartum; Type: EXPERIMENTAL; Interventions: Device: Levonorgestrel Intrauterine System (LNG-IUS: Mirena, Bayer) | Arm Label: Interval; Type: EXPERIMENTAL; Interventions: Device: Levonorgestrel Intrauterine System (LNG-IUS: Mirena, Bayer) | Intervention Type: DEVICE; Name: Levonorgestrel Intrauterine System (LNG-IUS: Mirena, Bayer); Assigned to Arm(s): Early Postpartum, Immediate Postplacental, Interval

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Multicenter Randomized Phase II Clinical Trial of Laparoscopy Assisted Versus Open Distal Gastrectomy With D2 Lymph Node Dissection for Advanced Gastric Cancer
Brief Summary: The purpose of this study is to evaluate the oncological feasibility of laparoscopy-assisted distal gastrectomy with D2 lymph node dissection for advanced gastric cancer.


Options:
A: Arm Label: Laparoscopy assisted distal gastrectomy; Type: EXPERIMENTAL; Interventions: Procedure: laparoscopy assisted distal gastrectomy | Arm Label: Open Distal Gastrectomy; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Open distal gastrectomy | Intervention Type: PROCEDURE; Name: laparoscopy assisted distal gastrectomy; Assigned to Arm(s): Laparoscopy assisted distal gastrectomy | Intervention Type: PROCEDURE; Name: Open distal gastrectomy; Assigned to Arm(s): Open Distal Gastrectomy
B: Arm Label: Open Gastrectomy; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Open Gastrectomy | Arm Label: Laparoscopic Gastrectomy; Type: EXPERIMENTAL; Interventions: Procedure: Laparoscopic Gastrectomy | Intervention Type: PROCEDURE; Name: Open Gastrectomy; Assigned to Arm(s): Open Gastrectomy | Intervention Type: PROCEDURE; Name: Laparoscopic Gastrectomy; Assigned to Arm(s): Laparoscopic Gastrectomy
C: Intervention Type: PROCEDURE; Name: laparoscopy-assisted distal gastrectomy; Assigned to Arm(s): N/A | Intervention Type: PROCEDURE; Name: open distal gastrectomy; Assigned to Arm(s): N/A
D: Arm Label: open distal gastrectomy; Type: ACTIVE_COMPARATOR; Interventions: Procedure: open distal gastrectomy | Arm Label: laparoscopy assisted distal gastrectomy; Type: EXPERIMENTAL; Interventions: Procedure: laparoscopy assisted distal gastrectomy | Intervention Type: PROCEDURE; Name: laparoscopy assisted distal gastrectomy; Assigned to Arm(s): laparoscopy assisted distal gastrectomy | Intervention Type: PROCEDURE; Name: open distal gastrectomy; Assigned to Arm(s): open distal gastrectomy

Answer: D